233 related articles for article (PubMed ID: 17642390)
1. Assessing the effectiveness of Dead Sea products as prophylactic agents for acute radiochemotherapy-induced skin and mucosal toxicity in patients with head and neck cancers: a phase 2 study.
Matceyevsky D; Hahoshen NY; Vexler A; Noam A; Khafif A; Ben-Yosef R
Isr Med Assoc J; 2007 Jun; 9(6):439-42. PubMed ID: 17642390
[TBL] [Abstract][Full Text] [Related]
2. Dead Sea products.
Ben-Yosef R; Yaal-Hahoshen N
Isr Med Assoc J; 2007 Oct; 9(10):765. PubMed ID: 17987774
[No Abstract] [Full Text] [Related]
3. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
4. Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial.
Kazemian A; Kamian S; Aghili M; Hashemi FA; Haddad P
Eur J Cancer Care (Engl); 2009 Mar; 18(2):174-8. PubMed ID: 19267733
[TBL] [Abstract][Full Text] [Related]
5. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer.
Rashad UM; Al-Gezawy SM; El-Gezawy E; Azzaz AN
J Laryngol Otol; 2009 Feb; 123(2):223-8. PubMed ID: 18485252
[TBL] [Abstract][Full Text] [Related]
6. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma.
Cerchietti LC; Navigante AH; Bonomi MR; Zaderajko MA; Menéndez PR; Pogany CE; Roth BM
Cancer; 2002 Nov; 95(10):2230-6. PubMed ID: 12412178
[TBL] [Abstract][Full Text] [Related]
7. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
[TBL] [Abstract][Full Text] [Related]
8. Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.
Palazzi M; Tomatis S; Orlandi E; Guzzo M; Sangalli C; Potepan P; Fantini S; Bergamini C; Gavazzi C; Licitra L; Scaramellini G; Cantu' G; Olmi P
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):330-7. PubMed ID: 17881148
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trial on continuous 7-days-a-week postoperative radiotherapy for high-risk squamous cell head-and-neck cancer: a report on acute normal tissue reactions.
Suwinski R; Bankowska-Wozniak M; Majewski W; Sowa A; Idasiak A; Ziolkowska E; Windorbska W; Tarnawski R; Skladowski K; Maciejewski B
Radiother Oncol; 2005 Oct; 77(1):58-64. PubMed ID: 16157401
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
[TBL] [Abstract][Full Text] [Related]
11. Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study.
Lin LC; Que J; Lin LK; Lin FC
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):745-50. PubMed ID: 16751063
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center.
Nonzee NJ; Dandade NA; Patel U; Markossian T; Agulnik M; Argiris A; Patel JD; Kern RC; Munshi HG; Calhoun EA; Bennett CL
Cancer; 2008 Sep; 113(6):1446-52. PubMed ID: 18683883
[TBL] [Abstract][Full Text] [Related]
13. Relationship between clinical factors and the incidence of toxicity after intra-arterial chemoradiation for head and neck cancer.
van den Broek GB; Balm AJ; van den Brekel MW; Hauptmann M; Schornagel JH; Rasch CR
Radiother Oncol; 2006 Nov; 81(2):143-50. PubMed ID: 17055096
[TBL] [Abstract][Full Text] [Related]
14. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
[TBL] [Abstract][Full Text] [Related]
15. Doxepin rinse for management of mucositis pain in patients with cancer: one week follow-up of topical therapy.
Epstein JB; Epstein JD; Epstein MS; Oien H; Truelove EL
Spec Care Dentist; 2008; 28(2):73-7. PubMed ID: 18402621
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein levels and radiation-induced mucositis in patients with head-and-neck cancer.
Ki Y; Kim W; Nam J; Kim D; Park D; Kim D
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):393-8. PubMed ID: 19362778
[TBL] [Abstract][Full Text] [Related]
17. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.
Elting LS; Cooksley CD; Chambers MS; Garden AS
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1110-20. PubMed ID: 17398022
[TBL] [Abstract][Full Text] [Related]
18. Actinic damage among patients with psoriasis treated by climatotherapy at the Dead Sea.
David M; Tsukrov B; Adler B; Hershko K; Pavlotski F; Rozenman D; Hodak E; Paltiel O
J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):445-50. PubMed ID: 15761422
[TBL] [Abstract][Full Text] [Related]
19. Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life.
Elting LS; Keefe DM; Sonis ST; Garden AS; Spijkervet FK; Barasch A; Tishler RB; Canty TP; Kudrimoti MK; Vera-Llonch M;
Cancer; 2008 Nov; 113(10):2704-13. PubMed ID: 18973181
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial.
Wu HG; Song SY; Kim YS; Oh YT; Lee CG; Keum KC; Ahn YC; Lee SW
Cancer; 2009 Aug; 115(16):3699-708. PubMed ID: 19514089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
